Literature DB >> 27555427

Disease-Related, Nondisease-Related, and Situational Catastrophizing in Sickle Cell Disease and Its Relationship With Pain.

Vani A Mathur1, Kasey B Kiley2, C Patrick Carroll2, Robert R Edwards3, Sophie Lanzkron4, Jennifer A Haythornthwaite2, Claudia M Campbell2.   

Abstract

Catastrophizing is a potent psychological modulator of pain across several chronic pain populations; yet despite evidence that patients with sickle cell disease (SCD) catastrophize more than patients with other chronic pain conditions, previous research indicates that catastrophizing is not related to sickle cell pain after controlling for relevant covariates such as depression. Recent research suggests that pain-related catastrophizing should be assessed across pain contexts (eg, dispositional and situational). In this study, we measured disease-specific, general non-disease-related, and situational catastrophizing and assessed the relationship between these contextual dimensions of catastrophizing and laboratory and clinical pain among patients with SCD. Results revealed differential catastrophizing across pain contexts, with patients reporting greater catastrophizing about SCD-specific pain compared with non-SCD pain and laboratory pain. SCD-specific and non-SCD catastrophizing were associated with clinical pain outcomes, and situational catastrophizing with markers of central sensitization and laboratory pain. Further examination of the time course of laboratory responses revealed that increases in situational catastrophizing were associated with subsequent increases in laboratory pain sensitivity. Taken together, results show the relevance of catastrophizing in understanding pain in SCD, and suggest that context-specific anchors may be beneficial in predicting different aspects of the pain experience (eg, chronic pain, pain sensitization). PERSPECTIVE: Patients with SCD report greater catastrophizing about sickle cell-specific pain relative to other pains. Disease-specific and non-disease-related pain catastrophizing were associated with clinical pain, and situational catastrophizing predictive of subsequent laboratory pain. Evaluation of context-specific catastrophizing may more accurately predict different aspects of the pain experience. Copyright Â
© 2016 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sickle cell disease; central sensitization; chronic pain; pain catastrophizing; quantitative sensory testing

Mesh:

Year:  2016        PMID: 27555427      PMCID: PMC5159277          DOI: 10.1016/j.jpain.2016.08.003

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  31 in total

Review 1.  Theoretical perspectives on the relation between catastrophizing and pain.

Authors:  M J Sullivan; B Thorn; J A Haythornthwaite; F Keefe; M Martin; L A Bradley; J C Lefebvre
Journal:  Clin J Pain       Date:  2001-03       Impact factor: 3.442

2.  The role of neuroticism, pain catastrophizing and pain-related fear in vigilance to pain: a structural equations approach.

Authors:  Liesbet Goubert; Geert Crombez; Stefaan Van Damme
Journal:  Pain       Date:  2004-02       Impact factor: 6.961

3.  Changes in situation-specific pain catastrophizing precede changes in pain report during capsaicin pain: a cross-lagged panel analysis among healthy, pain-free participants.

Authors:  Claudia M Campbell; Phillip J Quartana; Luis F Buenaver; Jennifer A Haythornthwaite; Robert R Edwards
Journal:  J Pain       Date:  2010-05-21       Impact factor: 5.820

4.  Situational versus dispositional measurement of catastrophizing: associations with pain responses in multiple samples.

Authors:  Claudia M Campbell; Tarek Kronfli; Luis F Buenaver; Michael T Smith; Chantal Berna; Jennifer A Haythornthwaite; Robert R Edwards
Journal:  J Pain       Date:  2010-05       Impact factor: 5.820

5.  An Evaluation of Central Sensitization in Patients With Sickle Cell Disease.

Authors:  Claudia M Campbell; Gyasi Moscou-Jackson; C Patrick Carroll; Kasey Kiley; Carlton Haywood; Sophie Lanzkron; Matthew Hand; Robert R Edwards; Jennifer A Haythornthwaite
Journal:  J Pain       Date:  2016-02-16       Impact factor: 5.820

Review 6.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

Review 7.  Pain catastrophizing: a critical review.

Authors:  Phillip J Quartana; Claudia M Campbell; Robert R Edwards
Journal:  Expert Rev Neurother       Date:  2009-05       Impact factor: 4.618

8.  Pain referents used to respond to the pain catastrophizing scale.

Authors:  S Kapoor; B E Thorn; O Bandy; K L Clements
Journal:  Eur J Pain       Date:  2015-03       Impact factor: 3.931

9.  Fear of pain, pain catastrophizing, and acute pain perception: relative prediction and timing of assessment.

Authors:  Adam T Hirsh; Steven Z George; Joel E Bialosky; Michael E Robinson
Journal:  J Pain       Date:  2008-05-16       Impact factor: 5.820

Review 10.  Thinking beyond sickling to better understand pain in sickle cell disease.

Authors:  Deepika S Darbari; Samir K Ballas; Daniel J Clauw
Journal:  Eur J Haematol       Date:  2014-05-16       Impact factor: 2.997

View more
  13 in total

1.  Daily Opioid Use Fluctuates as a Function of Pain, Catastrophizing, and Affect in Patients With Sickle Cell Disease: An Electronic Daily Diary Analysis.

Authors:  Patrick H Finan; C Patrick Carroll; Gyasi Moscou-Jackson; Marc O Martel; Claudia M Campbell; Alex Pressman; Joshua M Smyth; Jean-Michel Tremblay; Sophie M Lanzkron; Jennifer A Haythornthwaite
Journal:  J Pain       Date:  2017-09-21       Impact factor: 5.820

Review 2.  Pain-measurement tools in sickle cell disease: where are we now?

Authors:  Deepika S Darbari; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

3.  Acceptability and Feasibility of a Mindfulness-Based Intervention for Pain Catastrophizing among Persons with Sickle Cell Disease.

Authors:  Leigh Ann Simmons; Hants Williams; Susan Silva; Francis Keefe; Paula Tanabe
Journal:  Pain Manag Nurs       Date:  2019-05-10       Impact factor: 1.929

Review 4.  Neuropathic pain in sickle cell disease: measurement and management.

Authors:  Alexander Glaros; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

5.  Autonomically-mediated decrease in microvascular blood flow due to mental stress and pain in sickle cell disease: A target for neuromodulatory interventions.

Authors:  Sarah R Martin; Payal Shah; Christopher Denton; Lonnie K Zeltzer; Saranya Veluswamy; Michael C K Khoo; Thomas D Coates
Journal:  Complement Ther Med       Date:  2020-02-15       Impact factor: 2.446

6.  Disentangling trait versus state characteristics of the Pain Catastrophizing Scale and the PHQ-8 Depression Scale.

Authors:  Levent Dumenci; Kurt Kroenke; Francis J Keefe; Dennis C Ang; James Slover; Robert A Perera; Daniel L Riddle
Journal:  Eur J Pain       Date:  2020-06-27       Impact factor: 3.931

7.  Sex Differences in Interleukin-6 Responses Over Time Following Laboratory Pain Testing Among Patients With Knee Osteoarthritis.

Authors:  Chung Jung Mun; Janelle E Letzen; Sabrina Nance; Michael T Smith; Harpal S Khanuja; Robert S Sterling; Mark C Bicket; Jennifer A Haythornthwaite; Robert N Jamison; Robert R Edwards; Claudia M Campbell
Journal:  J Pain       Date:  2019-11-13       Impact factor: 5.820

8.  Preliminary evidence that hydroxyurea is associated with attenuated peripheral sensitization in adults with sickle cell disease.

Authors:  Janelle E Letzen; Sophie Lanzkron; Kasey Bond; Christopher Patrick Carroll; Jennifer A Haythornthwaite; Sabrina Nance; Claudia M Campbell
Journal:  Pain Rep       Date:  2019-03-22

9.  Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study.

Authors:  Julie Kanter; Miguel R Abboud; Banu Kaya; Videlis Nduba; Carl Amilon; Christer Gottfridsson; Martin Rensfeldt; Maria Leonsson-Zachrisson
Journal:  Br J Haematol       Date:  2018-11-16       Impact factor: 6.998

10.  Pain catastrophizing is associated with poorer health-related quality of life in pediatric patients with sickle cell disease.

Authors:  Nitya Bakshi; Ines Lukombo; Inna Belfer; Lakshmanan Krishnamurti
Journal:  J Pain Res       Date:  2018-05-08       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.